Medical devices, healthcare technology and the business of care
510(k) clearance · K262874

CraniUS Plate

CraniUS, LLC · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK262874

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for the CraniUS Plate, submitted by CraniUS, LLC of Baltimore, Maryland, under 510(k) number K262874. The decision date is September 11, 2026; the submission was received August 14, 2026. The device is a Class II preformed alterable cranioplasty plate under 21 CFR 882.5320, product code GWO, in the Neurology specialty. SESE means clearance to market, not premarket approval.

The CraniUS Plate is a patient-specific PEEK implant intended to fill a bony void or defect in the cranial skeleton, fixed with separately cleared cranial fixation screws and plates and supplied non-sterile. The 510(k) summary identifies K261058 (also named CraniUS Plate) as the predicate, with the same indications, material, size range and thickness. The stated change is an added optional opening pattern for an implantable intracranial pressure sensor, requested by the surgeon; reservoirs and sensors are not included. The summary reports biocompatibility, cleaning and sterilization, and mechanical testing, but the source does not give detailed test results or the full indications wording.

The letter text carries an internal date inconsistency, showing September 11, 2029 in one place, while the database and signature record September 11, 2026. No clinical outcome data are provided in the available excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262874
Regulatory pathway
510(k) premarket notification
Applicant
CraniUS, LLC
Product code
GWO
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Plate, Cranioplasty, Preformed, Alterable.

Applicant
CraniUS, LLC
Product code
GWO
FDA device class
2

FDA decision timeline

  1. K262874 received

    Application receipt date recorded by FDA.

  2. K262874 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

CraniUS, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Baltimore, MD

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records